MeiraGTx Holdings plc Interest Expense
MeiraGTx Holdings plc (MGTX) reported Interest Expense of $3.51 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-13
- MeiraGTx Holdings plc interest expense for the quarter ending 2026-06-30 was $3.51M, a 15.66% increase year-over-year.
- MeiraGTx Holdings plc interest expense for the quarter ending 2026-03-31 was $2.85M, a 6.41% decline year-over-year.
- MeiraGTx Holdings plc interest expense for the quarter ending 2025-12-31 was $3.06M, a 10.44% decline year-over-year.
- MeiraGTx Holdings plc interest expense for the quarter ending 2025-09-30 was $3.06M, a 8.70% decline year-over-year.
- MeiraGTx Holdings plc interest expense for fiscal 2025 was $12.20M, a 8.10% decline from fiscal 2024.
- MeiraGTx Holdings plc interest expense for fiscal 2024 was $13.27M, a 0.20% increase from fiscal 2023.
- MeiraGTx Holdings plc interest expense for fiscal 2023 was $13.24M, a 167.79% increase from fiscal 2022.
- MeiraGTx Holdings plc interest expense for fiscal 2022 was $4.95M, a 1617.36% increase from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.51M 10-Q · filed 2026-08-13 | $6.36M 10-Q · filed 2026-08-13 | $9.41M derived: sum of 3 quarters · filed 2026-08-13 | $12.48M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $2.85M 10-Q · filed 2026-05-14 | $5.90M derived: sum of 2 quarters · filed 2026-05-14 | $8.97M derived: sum of 3 quarters · filed 2026-05-14 | $12.00M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $6.12M derived: sum of 2 quarters · filed 2026-03-30 | $9.15M derived: sum of 3 quarters · filed 2026-08-13 | $12.20M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $3.06M 10-Q · filed 2025-11-13 | $6.10M derived: sum of 2 quarters · filed 2026-08-13 | $9.14M 10-Q · filed 2025-11-13 | $12.55M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $3.03M 10-Q · filed 2026-08-13 | $6.08M 10-Q · filed 2026-08-13 | $9.49M derived: sum of 3 quarters · filed 2026-08-13 | $12.85M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $3.04M 10-Q · filed 2026-05-14 | $6.45M derived: sum of 2 quarters · filed 2026-05-14 | $9.81M derived: sum of 3 quarters · filed 2026-05-14 | $13.06M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $3.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $6.77M derived: sum of 2 quarters · filed 2026-03-30 | $10.02M derived: sum of 3 quarters · filed 2026-03-30 | $13.27M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $3.36M 10-Q · filed 2025-11-13 | $6.61M derived: sum of 2 quarters · filed 2025-11-13 | $9.86M 10-Q · filed 2025-11-13 | $13.31M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $3.25M 10-Q · filed 2025-08-14 | $6.50M 10-Q · filed 2025-08-14 | $9.95M derived: sum of 3 quarters · filed 2025-08-14 | $13.33M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $3.25M 10-Q · filed 2025-05-13 | $6.70M derived: sum of 2 quarters · filed 2025-05-13 | $10.08M derived: sum of 3 quarters · filed 2025-05-13 | $13.44M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $3.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $6.83M derived: sum of 2 quarters · filed 2025-03-13 | $10.19M derived: sum of 3 quarters · filed 2025-03-13 | $13.24M 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | $3.38M 10-Q · filed 2024-11-13 | $6.74M derived: sum of 2 quarters · filed 2024-11-13 | $9.80M 10-Q · filed 2024-11-13 | $12.69M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $3.35M 10-Q · filed 2024-08-12 | $6.42M 10-Q · filed 2024-08-12 | $9.31M derived: sum of 3 quarters · filed 2024-08-12 | $11.20M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $3.06M 10-Q · filed 2024-05-09 | $5.96M derived: sum of 2 quarters · filed 2024-05-09 | $7.85M derived: sum of 3 quarters · filed 2024-05-09 | $7.93M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $4.79M derived: sum of 2 quarters · filed 2024-03-15 | $4.87M derived: sum of 3 quarters · filed 2024-03-15 | $4.95M 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | $1.89M 10-Q · filed 2023-11-14 | $1.97M derived: sum of 2 quarters · filed 2023-11-14 | $2.05M 10-Q · filed 2023-11-14 | $2.17M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $82.00K 10-Q · filed 2023-08-10 | $159.00K 10-Q · filed 2023-08-10 | $278.00K derived: sum of 3 quarters · filed 2023-08-10 | $337.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $77.00K 10-Q · filed 2023-05-11 | $196.00K derived: sum of 2 quarters · filed 2023-05-11 | $255.00K derived: sum of 3 quarters · filed 2023-05-11 | $306.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $178.00K derived: sum of 2 quarters · filed 2023-03-14 | $229.00K derived: sum of 3 quarters · filed 2023-03-14 | $288.00K 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | $59.00K 10-Q · filed 2022-11-10 | $110.00K derived: sum of 2 quarters · filed 2022-11-10 | $169.00K 10-Q · filed 2022-11-10 | $205.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $51.00K 10-Q · filed 2022-08-11 | $110.00K 10-Q · filed 2022-08-11 | $146.00K derived: sum of 3 quarters · filed 2022-08-11 | $181.00K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $59.00K 10-Q · filed 2022-05-12 | $95.00K derived: sum of 2 quarters · filed 2022-05-12 | $130.00K derived: sum of 3 quarters · filed 2022-05-12 | $164.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $71.00K derived: sum of 2 quarters · filed 2022-03-10 | $105.00K derived: sum of 3 quarters · filed 2022-03-10 | $139.00K 10-K · filed 2022-03-10 | $139.20K 10-K · filed 2021-03-11 | |||
| 2020-09-30 | $35.00K 10-Q · filed 2021-11-10 | $35.14K 10-Q · filed 2020-11-05 | $69.00K derived: sum of 2 quarters · filed 2021-11-10 | $103.00K 10-Q · filed 2021-11-10 | $103.15K 10-Q · filed 2020-11-05 | $123.30K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $34.00K 10-Q · filed 2021-08-11 | $34.05K 10-Q · filed 2020-08-06 | $68.00K 10-Q · filed 2021-08-11 | $68.01K 10-Q · filed 2020-08-06 | $88.30K derived: sum of 3 quarters · filed 2021-08-11 | $97.58K derived: sum of 4 quarters · filed 2021-08-11 | ||
| 2020-03-31 | $34.00K 10-Q · filed 2021-05-11 | $33.97K 10-Q · filed 2020-05-07 | $54.30K derived: sum of 2 quarters · filed 2021-05-11 | $63.58K derived: sum of 3 quarters · filed 2021-05-11 | $73.04K derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | $20.30K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $29.58K derived: sum of 2 quarters · filed 2021-03-11 | $39.04K derived: sum of 3 quarters · filed 2021-03-11 | $48.61K 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $9.28K 10-Q · filed 2020-11-05 | $18.74K derived: sum of 2 quarters · filed 2020-11-05 | $28.31K 10-Q · filed 2020-11-05 | $15.17K derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $9.45K 10-Q · filed 2020-08-06 | $19.03K 10-Q · filed 2020-08-06 | $5.89K derived: sum of 3 quarters · filed 2020-08-06 | $15.39K derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $9.57K 10-Q · filed 2020-05-07 | -$3.57K derived: sum of 2 quarters · filed 2020-05-07 | $5.94K derived: sum of 3 quarters · filed 2020-05-07 | $15.65K derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$13.14K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | -$3.63K derived: sum of 2 quarters · filed 2020-03-11 | $6.07K derived: sum of 3 quarters · filed 2020-03-11 | $33.43K 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $9.51K 10-Q · filed 2019-11-07 | $19.22K derived: sum of 2 quarters · filed 2019-11-07 | $46.57K 10-Q · filed 2019-11-07 | -$42.32K derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $9.71K 10-Q · filed 2019-08-07 | $37.06K 10-Q · filed 2019-08-07 | -$51.83K derived: sum of 3 quarters · filed 2019-08-07 | $20.91K derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $27.36K 10-Q · filed 2019-05-14 | -$61.54K derived: sum of 2 quarters · filed 2019-05-14 | $11.20K derived: sum of 3 quarters · filed 2019-05-14 | $62.09K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | -$88.89K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$16.16K derived: sum of 2 quarters · filed 2019-03-26 | $34.74K derived: sum of 3 quarters · filed 2019-03-26 | $42.86K 10-K · filed 2019-03-26 | ||||
| 2017-09-30 | $72.74K 10-Q · filed 2018-11-08 | $123.63K derived: sum of 2 quarters · filed 2018-11-08 | $131.76K 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | $50.89K 10-Q · filed 2018-08-08 | $59.02K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |